Navigation Links
Genstruct Names Louis Latino VP of Sales
Date:9/17/2008

ect sales experience. Prior to joining Genstruct, he was VP of North America, Life Sciences Sales and Support for Accelrys, Inc., a developer of a broad range of technologies, including computer-aided-molecular-design and scientific business intelligence software. He honed his life sciences expertise as VP of Worldwide Sales for Geneformatics and as a regional sales manager for Biosym Technologies. In both positions, he exceeded revenue goals and increased profitability for the respective companies, while enhancing the impact of their technologies.

Mr. Latino has also held senior sales positions with Superscape Group, Mitchell Management Systems and BIW Cable Systems. He earned his bachelor's degree in chemistry from Boston College.

About Genstruct

Founded in 2002, Genstruct is a systems biology company focused on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. By developing Causal Network(TM) models for complex biological systems, Genstruct develops a deep molecular understanding of diseases and drug action, and designs mechanistic biomarkers and molecular diagnostics to facilitate drug development and personalized medicine. Genstruct's Consulting Services division engages in short-, mid- and long-term partnerships with top tier pharmaceutical and life sciences companies, to develop new therapeutics and mechanistic biomarkers in the areas of oncology, metabolic disorders, cardiovascular diseases and inflammation. Genstruct was awarded the Bio-IT World 2008 Best Practices Award in the Drug Discovery & Development category for its joint collaboration with Sirtris Pharmaceuticals (a GSK company). Genstruct is a privately held company based in Cambridge, Mass. For more information, please visit http://www.genstruct.com.

Genstruct and the Genstruct logo are registered trademarks and Molecular Epistemics, Knowledge Assem
'/>"/>

SOURCE Genstruct Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Genstruct and Sirtris Pharmaceuticals Win Bio-IT Worlds Best Practices Award
2. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
3. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
4. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
5. Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
6. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
7. ThermoGenesis Names Tiffany Olson to Board of Directors
8. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
9. eResearchTechnology Names New Chief Financial Officer
10. HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations
11. The TPAA Names Mark Oelschlager President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... , April 30, 2015  The Paul G. Allen ... Investigator (ADI) grants to six groups of researchers with ... challenging roadblocks in neuroscience: growing mature human brain cells ... total of $7.5 million over three years.  ... their research is especially significant because the field of ...
(Date:4/30/2015)... 2015 Available in select spas ... , Fleur’s introduces CC CRÈME ... benefits of makeup, skin care and solar protection ... is designed with specific complexion-correcting pigments to instantly ... and a healthy glow. Far more than a ...
(Date:4/29/2015)... 2015 According to a new ... Product (Portable & Non-Portable), Component (Accelerometer, Proximity Probe, ... Metal & Mining, & Others), & Geography - ... expected to reach $1,453.76 Million by 2020, at ... data tables and 92 figures spread through 205 ...
(Date:4/29/2015)... AlloSource ®, one of the ... and soft-tissue allografts for use in surgical procedures ... the launch of AlloSkin™ AC, an acellular dermal ... (CMS) also moved AlloSkin™ RT, a meshed human ... category for reimbursement. "AlloSource is committed ...
Breaking Biology Technology:The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 2The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 3The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 4The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 5Fleur’s Introduces CC CRÈME Perfect Skin Solution 2Fleur’s Introduces CC CRÈME Perfect Skin Solution 3Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 2Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 3Vibration Monitoring Equipment (Portable & Non-Portable) Market worth $1,453.76 Million by 2020 - New Report by MarketsandMarkets 4AlloSource Announces New Possibilities In Wound Care 2
... , June 17 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ... been granted its 35th U.S. Patent, # 7,731,951 entitled "Viruses for ... for treating cell proliferative disorders by administering modified vaccinia virus to ... , , ...
... June 17 ChemoCentryx, Inc., today announced that ... drug candidate CCX354 at the Annual European Congress of ... drug candidate designed to specifically target the CCR1 chemokine ... (RA).  Data demonstrating that CCX354 was safe and well ...
... Researchers at Rensselaer Polytechnic Institute have developed a ... that measure only billionths of a meter thick. ... works on nearly any surface including silicon wafers, ... manufacturing. Sang-Kee Eah, assistant professor in the ...
Cached Biology Technology:Oncolytics Biotech(R) Inc. Announces Issuance of 35th U.S. Patent 2ChemoCentryx Reports Positive Phase I Study Results for CCX354 at the Annual European Congress of Rheumatology (EULAR) 2ChemoCentryx Reports Positive Phase I Study Results for CCX354 at the Annual European Congress of Rheumatology (EULAR) 3ChemoCentryx Reports Positive Phase I Study Results for CCX354 at the Annual European Congress of Rheumatology (EULAR) 4Researchers develop ultra-simple method for creating nanoscale gold coatings 2
(Date:3/31/2015)... March 31, 2015   Guidepoint , a leading ... the Post-Surgical Pain Management TRACKER, part of the ... trends in the medical device and therapeutics markets. The ... including treatment volumes, market share, and adoption rates across ... with joint surgery. The Post-Surgical Pain Management ...
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... critical security-authentication needs, today announced the beginning of shipments ... solution. The company, based in ... the three-day Connect:ID Expo, which began here today at ... said version 2.0 of its SDK boosts the accuracy ...
(Date:3/23/2015)... OXFORD, Conn. , Mar. 23, 2015 NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, announces ... a new advertising campaign on CNBC television starting March 30 ... ads will commence airing in New York ... Executive Officer said: "We are excited about our new ad ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... 24, 2013 For the first time, scientists at ... moderate-severe traumatic brain injury (TBI), atrophy (shrinkage) in the ... increased physical, social and cognitive stimulation. The ... in the chronic stages of traumatic brain injury," was ...
... (Sept. 24, 2013) Retinal (or fundus) photography is ... cameras can cost tens to hundreds of thousands of ... ophthalmic practices and to physicians in third-world countries. In ... Ear researchers describe the relatively simple technique of fundus ...
... researchers have identified and validated two rare gene mutations that ... that strikes after the age of 60. The two mutations ... enzyme involved in processing the amyloid precursor protein which ... the fifth AD gene overall. In their ...
Cached Biology News:Scientists discover environmental enrichment for TBI patients may counter shrinkage in the brain 2Scientists discover environmental enrichment for TBI patients may counter shrinkage in the brain 3Researchers use smart phone photography to diagnose eye disease 2Study confirms that rare mutations increase risk of late-onset Alzheimer's disease 2Study confirms that rare mutations increase risk of late-onset Alzheimer's disease 3
Rabbit polyclonal to Dishevelled 2 ( Abpromise for all tested applications). entrezGeneID: 1856 SwissProtID: O14641...
... Mouse anti-Cytohesin 2, Monoclonal Antibody, Unconjugated ... assay dependent dilution. ICC: Use at an assay ... 5 - 10 ug/ml, this concentration is determined ... molecular weight: 40 kDa. Not tested in other ...
SHP-2 Antibody...
... Transporter 2, Neuronal (GLYT2). The antiserum has ... central nervous system. The staining pattern obtained ... using in situ hybridization with probes to ... described for glycinergic neurons. Preabsorption of the ...
Biology Products: